Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. class III β-tubulin

Arrested neural and advanced mesenchymal differentiation of glioblastoma cells-comparative study with neural progenitors

(2009) Piotr Rieske et al.   BMC CANCER

Overexpression of Class III  -Tubulin Predicts Good Response to Taxane-Based Chemotherapy in Ovarian Clear Cell Adenocarcinoma

(2009) D. Aoki et al.   CLINICAL CANCER RESEARCH

Identification and Characterization of an Intermediate Taxol Binding Site Within Microtubule Nanopores and a Mechanism for Tubulin Isotype Binding Selectivity

(2009) Holly Freedman et al.   Journal of Chemical Information and Modeling

Loss of Class III β-Tubulin Induced by Histone Deacetylation Is Associated with Chemosensitivity to Paclitaxel in Malignant Melanoma Cells

(2009) Kiyomi Akasaka et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Class III β-Tubulin Is Constitutively Coexpressed With Glial Fibrillary Acidic Protein and Nestin in Midgestational Human Fetal Astrocytes: Implications for Phenotypic Identity

(2009) Eduarda Dráberová et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Ixabepilone: targeting  III-tubulin expression in taxane-resistant malignancies

(2009) C. Dumontet et al.   MOLECULAR CANCER THERAPEUTICS

Preclinical discovery of ixabepilone, a highly active antineoplastic agent

(2008) Francis Y. F. Lee et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo

(2008) Terence O’Reilly et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Molecular Mechanisms of Patupilone Resistance

(2008) S. Mozzetti et al.   CANCER RESEARCH

The Taccalonolides: Microtubule Stabilizers That Circumvent Clinically Relevant Taxane Resistance Mechanisms

(2008) April L. Risinger et al.   CANCER RESEARCH

DNA repair and cancer stem-like cells – Potential partners in glioma drug resistance?

(2008) Tor-Christian Aase Johannessen et al.   CANCER TREATMENT REVIEWS

Class III  -Tubulin Isotype Predicts Response in Advanced Breast Cancer Patients Randomly Treated Either with Single-Agent Doxorubicin or Docetaxel

(2008) C. M. Galmarini et al.   CLINICAL CANCER RESEARCH

Roles of β-Tubulin Residues Ala428and Thr429in Microtubule Formationin Vivo

(2008) Patrick A. Joe et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis

(2008) Christine E. Eyler et al.   JOURNAL OF CLINICAL ONCOLOGY

Endothelial Cell Barrier Impairment Induced by Glioblastomas and Transforming Growth Factor β2Involves Matrix Metalloproteinases and Tight Junction Proteins

(2008) Hideyuki Ishihara et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Is class III β-tubulin a predictive factor in patients receiving tubulin-binding agents?

(2008) Pascal Sève et al.   LANCET ONCOLOGY

Expression of excision repair cross-complementation group 1 and class III β-tubulin predict survival after chemotherapy for completely resected non-small cell lung cancer

(2008) Katsuhiro Okuda et al.   LUNG CANCER

Proteomic characterization of cytoskeletal and mitochondrial class III  -tubulin

(2008) L. Cicchillitti et al.   MOLECULAR CANCER THERAPEUTICS

Gliotypic Neural Stem Cells Transiently Adopt Tumorigenic Properties During Normal Differentiation

(2008) Noah M. Walton et al.   STEM CELLS

The roles of cys124 and ser239 in the functional properties of human βIII tubulin

(2008) Patrick A. Joe et al.   CELL MOTILITY AND THE CYTOSKELETON

Cancer stem cells and glioma

(2008) Sunit Das et al.   Nature clinical practice. Neurology

Hypoxia induces class III beta-tubulin gene expression by HIF-1α binding to its 3' flanking region

(2007) Giuseppina Raspaglio et al.   GENE